title: Marine n-3 polyunsaturated fatty acids and coronary heart disease. Part I. Background, epidemiology, animal data, effects on risk factors and safety.
abstract: In this paper, we will give an overview of the background for the possible effects of long-chain marine n-3 (synonymously called omega-3) polyunsaturated fatty acids (PUFA) in coronary heart disease (CHD) with focus on recent findings. In a forthcoming paper, we will focus on the clinical trial data, current recommendations and suggest trials to further study the role of marine n-3 PUFA in the prevention and treatment of CHD.
authors.affiliation: Department of Preventive Cardiology, Aalborg Sygehus, Arhus University Hospitals, Arhus, Denmark. ebs@aas.nja.dk
authors.forename: Erik Berg
authors.initials: EB
authors.lastname: Schmidt
authors.forename: Harald
authors.initials: H
authors.lastname: Arnesen
authors.forename: Raffaele
authors.initials: R
authors.lastname: de Caterina
authors.forename: Lars Hvilsted
authors.initials: LH
authors.lastname: Rasmussen
authors.forename: Steen Dalby
authors.initials: SD
authors.lastname: Kristensen
mesh_terms: D000818:Animals; D003327:Coronary Disease / Q000453:epidemiology* / Q000517:prevention & control; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage* / Q000009:adverse effects / Q000737:chemistry; D005395:Fish Oils / Q000008:administration & dosage; D005399:Fishes; D006801:Humans; D012307:Risk Factors
chemical_list: D015525:Fatty Acids, Omega-3; D005395:Fish Oils